US Bancorp DE lowered its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS – Get Rating) by 30.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,908 shares of the company’s stock after selling 1,264 shares during the period. US Bancorp DE’s holdings in Addus HomeCare were worth $278,000 as of its most recent filing with the SEC.
→ Hot craft spirits opportunity you don’t want to miss (From UNKNOWN)
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Shell Asset Management Co. boosted its position in Addus HomeCare by 62.7% during the 2nd quarter. Shell Asset Management Co. now owns 4,434 shares of the company’s stock valued at $369,000 after buying an additional 1,709 shares during the period. Assetmark Inc. boosted its position in Addus HomeCare by 110.1% during the 2nd quarter. Assetmark Inc. now owns 374 shares of the company’s stock valued at $31,000 after buying an additional 196 shares during the period. Ziegler Capital Management LLC boosted its position in Addus HomeCare by 12.3% during the 3rd quarter. Ziegler Capital Management LLC now owns 101,653 shares of the company’s stock valued at $9,681,000 after buying an additional 11,118 shares during the period. Seizert Capital Partners LLC purchased a new stake in Addus HomeCare during the 2nd quarter valued at $1,552,000. Finally, Tributary Capital Management LLC boosted its position in Addus HomeCare by 103.9% during the 3rd quarter. Tributary Capital Management LLC now owns 116,417 shares of the company’s stock valued at $11,088,000 after buying an additional 59,335 shares during the period. Institutional investors own 97.42% of the company’s stock.
Insider Buying and Selling
In related news, CFO Brian Poff sold 3,711 shares of the stock in a transaction dated Thursday, November 3rd. The shares were sold at an average price of $107.75, for a total value of $399,860.25. Following the completion of the transaction, the chief financial officer now directly owns 22,954 shares in the company, valued at approximately $2,473,293.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CFO Brian Poff sold 3,711 shares of Addus HomeCare stock in a transaction that occurred on Thursday, November 3rd. The shares were sold at an average price of $107.75, for a total value of $399,860.25. Following the completion of the sale, the chief financial officer now directly owns 22,954 shares in the company, valued at $2,473,293.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP David W. Tucker sold 268 shares of Addus HomeCare stock in a transaction that occurred on Monday, November 28th. The stock was sold at an average price of $107.09, for a total transaction of $28,700.12. Following the completion of the sale, the executive vice president now owns 7,952 shares of the company’s stock, valued at $851,579.68. The disclosure for this sale can be found here. Insiders sold a total of 32,714 shares of company stock worth $3,524,933 in the last three months. 4.50% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
Several brokerages have weighed in on ADUS. Royal Bank of Canada increased their price target on shares of Addus HomeCare from $110.00 to $121.00 and gave the company an “outperform” rating in a research report on Wednesday, November 2nd. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 14th. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $112.60.
Addus HomeCare Stock Down 2.4 %
Shares of Addus HomeCare stock opened at $107.16 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.87 and a quick ratio of 1.87. The company has a 50-day moving average of $104.70 and a 200 day moving average of $99.38. The firm has a market cap of $1.73 billion, a price-to-earnings ratio of 38.97, a PEG ratio of 2.85 and a beta of 0.82. Addus HomeCare Co. has a 1 year low of $68.57 and a 1 year high of $112.89.
Addus HomeCare (NASDAQ:ADUS – Get Rating) last issued its quarterly earnings results on Monday, October 31st. The company reported $0.80 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.01). The business had revenue of $240.50 million during the quarter, compared to the consensus estimate of $242.21 million. Addus HomeCare had a return on equity of 8.46% and a net margin of 4.77%. The firm’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.80 earnings per share. As a group, sell-side analysts anticipate that Addus HomeCare Co. will post 3.11 earnings per share for the current fiscal year.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.
Read More
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Get Rating).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Addus HomeCare, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Addus HomeCare wasn’t on the list.
While Addus HomeCare currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: news.google.com
